HK Stock MarketDetailed Quotes
01244 3D MEDICINES
- 5.860
- +0.210+3.72%
Market Closed Apr 24 16:08 CST
1.51BMarket Cap-2613P/E (TTM)
6.000High5.510Low1.44MVolume5.720Open5.650Pre Close8.26MTurnover0.56%Turnover RatioLossP/E (Static)258.21MShares131.50052wk High1.46P/B1.51BFloat Cap4.68052wk Low--Dividend TTM258.21MShs Float131.500Historical High--Dividend LFY8.67%Amplitude4.680Historical Low5.737Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
3D MEDICINES Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|
| Turnover | 11.91%634.95M | --352.55M | 841.57%567.39M | --60.26M | ---- | ---- |
| Operating income | 11.91%634.95M | 352.55M | 841.57%567.39M | 60.26M | ||
| Cost of sales | -16.29%-49.09M | ---27.3M | -887.02%-42.22M | ---4.28M | ---- | ---- |
| Operating expenses | -16.29%-49.09M | -27.3M | -887.02%-42.22M | -4.28M | ||
| Gross profit | 11.55%585.86M | 325.25M | 838.10%525.18M | 55.98M | ||
| Selling expenses | -5.91%-378.81M | ---220.97M | -734.99%-357.66M | ---42.83M | ---- | ---- |
| Administrative expenses | -51.98%-217.08M | ---78.37M | 5.38%-142.83M | -272.47%-150.96M | 1.37%-40.53M | ---41.09M |
| Research and development expenses | -21.27%-425.5M | ---151.61M | 5.47%-350.86M | -40.61%-371.16M | -15.07%-263.97M | ---229.39M |
| Revaluation surplus | ---- | ---- | 31.17%-657.16M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| -Changes in the fair value of other assets | ---- | ---- | 31.17%-657.16M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| Impairment and provision | 171.23%837K | ---277K | -803.85%-1.18M | ---130K | ---- | ---- |
| -Other impairment is provision | 171.23%837K | ---277K | -803.85%-1.18M | ---130K | ---- | ---- |
| Special items of operating profit | -86.31%-120.01M | ---60.19M | -1,917.47%-64.41M | 198.66%3.54M | 89.25%-3.59M | ---33.41M |
| Operating profit | 47.12%-554.69M | -186.16M | 28.17%-1.05B | -132.78%-1.46B | -105.53%-627.32M | -305.23M |
| Financing cost | -149.66%-7.77M | ---4.04M | -103.73%-3.11M | 81.04%-1.53M | 47.01%-8.06M | ---15.21M |
| Earning before tax | 46.54%-562.47M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Tax | ---55K | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 46.53%-562.52M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Earning after tax | 46.53%-562.52M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Minority profit | -36.65%-37.82M | ---11.72M | 0.19%-27.68M | ---27.73M | ---- | ---- |
| Profit attributable to shareholders | 48.78%-524.7M | -178.49M | 28.57%-1.02B | -125.71%-1.43B | -98.29%-635.38M | -320.43M |
| Basic earnings per share | 89.79%-2.3 | -0.79 | 38.67%-22.52 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Diluted earnings per share | 89.79%-2.3 | -0.79 | 38.67%-22.52 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg